We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · October 20, 2021

Predictive Significance of an Optimized Panel for Basal-Like Breast Cancer

Clinical Cancer Research

 

Additional Info

Clinical Cancer Research
Predictive significance of an optimized panel for basal-like breast cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 phase III clinical trials
Clin. Cancer Res 2021 Oct 06;[EPub Ahead of Print], K Asleh, D Tu, D Gao, V Bramwell, MN Levine, KI Pritchard, LE Shepherd, TO Nielsen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading